Dr. Vaishampayan is a Professor of Internal Medicine at the University of Michigan, Ann Arbor, and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She is the Director of the Multitumor Experimental Therapeutics Team/ Phase I program and is co-leader of the Translational and Clinical Research Program (TACR) at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at Wayne State University until 2020. She has completed formal leadership training course and is Fellow of the Advisory Board (FAB). She was appointed Chief of the Ambulatory Care Center for Medical Oncology in 2020.
She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track.
Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.
In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. She also loves watching football, both professional and college.